CONMED CORPORATION Proceeds from Issuance of Warrants
CONMED CORPORATION (CNMD) reported Proceeds from Issuance of Warrants of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-18.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2025-02-18
- CONMED CORPORATION proceeds from issuance of warrants for the quarter ending 2023-12-31 was $0.00.
- CONMED CORPORATION proceeds from issuance of warrants for the quarter ending 2023-09-30 was $0.00.
- CONMED CORPORATION proceeds from issuance of warrants for the quarter ending 2022-12-31 was $0.00.
- CONMED CORPORATION proceeds from issuance of warrants for the quarter ending 2022-09-30 was $0.00.
- CONMED CORPORATION proceeds from issuance of warrants for fiscal 2024 was $0.00.
- CONMED CORPORATION proceeds from issuance of warrants for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- CONMED CORPORATION proceeds from issuance of warrants for fiscal 2022 was $72.00M.
- CONMED CORPORATION proceeds from issuance of warrants for fiscal 2021 was $0.00.
| Period end | Proceeds from Issuance of Warrants | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-18 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $0.00 derived: sum of 2 quarters · filed 2025-02-18 | $0.00 10-K · filed 2025-02-18 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $0.00 10-Q · filed 2023-10-26 | |||
| 2023-06-30 | $0.00 10-Q · filed 2023-07-27 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $0.00 derived: sum of 2 quarters · filed 2025-02-18 | $72.00M 10-K · filed 2025-02-18 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $72.00M 10-Q · filed 2023-10-26 | |||
| 2022-06-30 | $72.00M 10-Q · filed 2023-07-27 | ||||
| 2022-06-06 | $72.00M 10-K · filed 2025-02-18 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $0.00 10-K · filed 2024-02-28 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $0.00 10-Q · filed 2022-10-27 | |||
| 2021-06-30 | $0.00 10-Q · filed 2022-07-28 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $0.00 derived: sum of 2 quarters · filed 2023-02-21 | $0.00 derived: sum of 3 quarters · filed 2023-02-21 | $0.00 10-K · filed 2023-02-21 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $0.00 derived: sum of 2 quarters · filed 2020-10-29 | $0.00 10-Q · filed 2020-10-29 | $0.00 derived: sum of 4 quarters · filed 2022-02-22 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $0.00 10-Q · filed 2020-07-30 | $0.00 derived: sum of 3 quarters · filed 2022-02-22 | $0.00 derived: sum of 4 quarters · filed 2022-02-22 | |
| 2020-03-31 | $0.00 10-Q · filed 2020-04-30 | $0.00 derived: sum of 2 quarters · filed 2022-02-22 | $0.00 derived: sum of 3 quarters · filed 2022-02-22 | $0.00 derived: sum of 4 quarters · filed 2022-02-22 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $0.00 derived: sum of 2 quarters · filed 2022-02-22 | $0.00 derived: sum of 3 quarters · filed 2022-02-22 | $30.57M 10-K · filed 2022-02-22 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $0.00 derived: sum of 2 quarters · filed 2020-10-29 | $30.57M 10-Q · filed 2020-10-29 | $30.57M derived: sum of 4 quarters · filed 2021-02-22 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $30.57M 10-Q · filed 2020-07-30 | $30.57M derived: sum of 3 quarters · filed 2021-02-22 | $30.57M derived: sum of 4 quarters · filed 2021-02-22 | |
| 2019-03-31 | $30.57M 10-Q · filed 2020-04-30 | $30.57M derived: sum of 2 quarters · filed 2021-02-22 | $30.57M derived: sum of 3 quarters · filed 2021-02-22 | $30.57M derived: sum of 4 quarters · filed 2021-02-22 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $0.00 derived: sum of 2 quarters · filed 2021-02-22 | $0.00 derived: sum of 3 quarters · filed 2021-02-22 | $0.00 10-K · filed 2021-02-22 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $0.00 derived: sum of 2 quarters · filed 2019-10-31 | $0.00 10-Q · filed 2019-10-31 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | |||
| 2018-03-31 | $0.00 10-Q · filed 2019-04-26 | ||||
| 2017-12-31 | $0.00 10-K · filed 2020-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |